Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
-- Phase III ADVOCATE trial of avacopan in treatment of ANCA vasculitis nears 75% ...
ZEJULA is the first and only PARP inhibitor to be approved for the maintenance ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
